ZURICH (Reuters) - Novartis has signed a licensing deal to hand over its experimental tuberculosis (TB) drugs to the Global Alliance for TB Drug Development, joining a growing Big Pharma retreat from antibiotics.
via Reuters: Health News Read More Here..
No comments:
Post a Comment